title: miRNAs and HIV: unforeseen determinants of host-pathogen interaction.
abstract: Our understanding of the complexity of gene regulation has significantly improved in the last decade as the role of small non-coding RNAs, called microRNAs (miRNAs), has been appreciated. These 19-22 nucleotide RNA molecules are critical regulators of mRNA translation and turnover. The miRNAs bind via a protein complex to the 3' untranslated region (3' UTR) of mRNA, ultimately leading to mRNA translational inhibition, degradation, or repression. Although many mechanisms by which human immunodeficiency virus-1 (HIV-1) infection eventually induces catastrophic immune destruction have been elucidated, the important role that miRNAs play in HIV-1 pathogenesis is only now emerging. Accumulating evidence demonstrates that changes to endogenous miRNA levels following infection is important: in maintaining HIV-1 latency in resting CD4(+) T cells, potentially affect immune function via changes to cytokines such as interleukin-2 (IL-2) and IL-10 and may predict disease progression. We review the roles that both viral and host miRNAs play in different cell types and disease conditions that are important in HIV-1 infection and discuss how miRNAs affect key immunomodulatory molecules contributing to immune dysfunction. Further, we discuss whether miRNAs may be used as novel biomarkers in serum and the potential to modulate miRNA levels as a unique approach to combating this pathogen.
authors.affiliation: Laboratory of Human Retrovirology, Applied and Developmental Research Directorate (ADD), Science Application International Corporation (SAIC)-Frederick, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
authors.forename: Sanjay
authors.initials: S
authors.lastname: Swaminathan
authors.forename: Daniel D
authors.initials: DD
authors.lastname: Murray
authors.forename: Anthony D
authors.initials: AD
authors.lastname: Kelleher
mesh_terms: D000818:Animals; D015415:Biomarkers; D018014:Gene Transfer Techniques; D015658:HIV Infections / Q000235:genetics* / Q000276:immunology* / Q000628:therapy / Q000821:virology; D015497:HIV-1 / Q000502:physiology*; D006680:HLA Antigens / Q000235:genetics / Q000276:immunology; D054884:Host-Pathogen Interactions / Q000235:genetics / Q000276:immunology; D006801:Humans; D035683:MicroRNAs / Q000235:genetics* / Q000627:therapeutic use; D012367:RNA, Viral
chemical_list: D015415:Biomarkers; D006680:HLA Antigens; D035683:MicroRNAs; D012367:RNA, Viral